JobCubby JobCubby
Sign up
ProKidney

ProKidney

A Potential New Era in the Treatment of CKD

LinkedIn
Location
—
Roles tracked
0
In pipeline
0
Tracking since
—

At a glance

You're tracking 0 roles at ProKidney. Track a role to start building momentum here.

Company intel

From the job board · LinkedIn data via posting sync
Industry
Biotechnology Research
Company size
235 people
Headquarters
Winston-Salem, North Carolina +3 more
Type
Public Company
Total funding
$345.0M

ProKidney, a pioneer in the treatment of chronic kidney disease through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney’s lead product candidate, rilparencel (also known as REACT®), is a first-in-class, patented, proprietary autologous cellular therapy being evaluated in Phase 2 and Phase 3 studies for its potential to preserve kidney function in diabetic patients at high risk of kidney failure. Rilparencel has received Regenerative Medicine Advanced Therapy (RMAT) designation from the FDA. For more information, please visit www.prokidney.com.

Health Care Therapeutics
1 open role at ProKidney on the job board

Open roles at ProKidney